Replies to post #131950 on Anavex Life Sciences Corp (AVXL)

[Mikesc]

Alkermes CEO Richard Pops had this to say on Biogen’s behalf:

Biogen has a broad product portfolio and a highly experienced commercial team. In Biogen’s hands, we believe that patients will have broader and more rapid access to this important medicine. Meanwhile, we will focus our growing commercial capabilities on our expanding portfolio of medicines in psychiatry, including addiction, schizophrenia and depression.

My interpretation.... this was a throw away drug anyway... Let BIIB spend the $$$ to bring this mediocre drug to market and we get a few bucks.